Kovitz Investment Group Partners
CNMD icon

Kovitz Investment Group Partners’s CONMED CNMD Stock Holding History

Kovitz Investment Group Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,427
Closed -$208K – 611
2025
Q3 		$208K Buy
4,427
+484
+12% +$25.1K ﹤0.01% 1328
2025
Q2 		$205K Buy
3,943
+561
+17% +$30.8K ﹤0.01% 1274
2025
Q1 		$204K Buy
3,382
+3
+0.1% +$193 ﹤0.01% 1177
2024
Q4 		$231K Buy
+3,379
New +$235K ﹤0.01% 1120

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Kovitz Investment Group Partners's CNMD Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of CONMED (CNMD) in Q4 2025, closing a stake of 4,427 shares — an estimated $208K sold.

Kovitz Investment Group Partners first reported a position in CNMD in Q4 2024 and held it in 4 quarters. The position peaked at $231K in Q4 2024. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 4,427 CONMED shares in Q4 2025, an estimated $208K.
  • Kovitz Investment Group Partners first reported a position in CONMED in Q4 2024 and held it in 4 quarters.
  • Kovitz Investment Group Partners's CONMED position peaked at $231K in Q4 2024.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.